Beyond Glucose Control
نویسندگان
چکیده
The number of diabetic patients is increasing at an alarming rate and, according to the World Health Organisation, is estimated to reach 300 million worldwide by the year 2025. Coronary heart disease is the leading cause of death in these patients. Diabetic patients are 2 to 3 times more likely to develop coronary heart disease, and they experience worse clinical outcomes after coronary artery angioplasty, cardiac bypass surgery, acute myocardial infarction, and the onset of cardiac failure. Clearly, new treatment strategies that are specifically directed to improving clinical outcomes in diabetic patients with coronary heart disease and in those patients who develop cardiac failure need to be developed.
منابع مشابه
Effectiveness of Tailored Care Intervention Program on Biochemical Outcomes of Patients with Diabetes in Indonesia: A Randomized Controlled Trial
Background: Although people with diabetes have common problems, their educational needs may be different and they all have the right to participate in the planning and implementation of individual or group health care programs. Meanwhile, there are no proper care interventions for diabetic patients in Indonesia. Therefore, the aim of this study was to evaluate the efficacy of a tailored care in...
متن کاملMoving beyond tight glucose control to safe effective glucose control
The impressive benefits related to the use of tight glucose control by intensive insulin therapy have not been reproduced until now in multicenter large-scale prospective randomized trials. Although the reasons for these failures are not entirely clear, we suggest the use of a stepwise approach - Safe, Effective Glucose Control - that will essentially target an intermediate blood glucose level....
متن کاملResidual insulin secretion in adolescent diabetics after remission.
Twenty four hour blood glucose profiles were compared in two groups of insulin dependent adolescent diabetic patients who were beyond their initial partial remission phase. In the group with persistent endogenous insulin secretion, blood glucose profiles were significantly lower but the difference was small and not reflected in average 24 hour concentrations of glucose nor glycosylated haemoglo...
متن کاملDPP 4 (dipeptidylpeptidase-4) inhibitors: beyond glycemic control
Type 2 diabetes is characterized by impaired insulin release from β-cell of pancreas and insulin resistance. Different classes of hypoglycemic drugs are available with different mechanism of action with nearly equipotent efficacy. GLP-1(glucagon like peptide-1) analogue and DPP 4 inhibitors are new developed molecules for the management of diabetes. They act via glucose dependent insulin releas...
متن کاملHighly Efficient In Vitro Production of Bovine Blastocyst in Cell-Free Sequential Synthetic Oviductal Fluid vs. TCM199 Vero Cell Co-Culture System
Background The aim of this study was to establish a cell-free sequential culture system that can support high levels of in vitro embryo development and blastocyst formation from bovine zygotes. To this end, this investigation was carried out to evaluate the effects of glucose, serum and EDTA on bovine zygote in vitro development. MaterialsAndMethods Bovine presumptive zygotes were derived from ...
متن کاملNephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
Current therapy directed at delaying the progression of diabetic nephropathy includes intensive glycemic and optimal blood pressure control, renin angiotensin-aldosterone system blockade and multifactorial intervention. However, the renal protection provided by these therapeutic modalities is incomplete. There is a scarcity of studies analysing the nephroprotective effect of antihyperglycaemic ...
متن کامل